Milan Zdravkovic joins Sobi as Senior Vice President, Head of Research & Development
Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO: SOBI) today announced that Milan Zdravkovic has been appointed Senior Vice President, Head of Research & Development (R&D). Milan joins Sobi from Novo Nordisk where he has had an 18 year tenure in the Research and Development organisation responsible for therapeutic areas including diabetes, growth hormone deficiency, obesity and immunology. Milan’s experience spans early stage development to post-approval life-cycle management in these areas. His most recent role was as Corporate Vice President, Obesity. “We are